Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 1.01, 5.02, 7.01, 9.01 · 8-K

Digimarc Corporation

DMRCNASDAQEQUITYCurrent

Entry into a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

Item 1.01. Entry into a Material Definitive Agreement Cooperation Agreement with Ocho Investments LLC On November 15, 2026 (the “Effective Date”), Digimarc Corporation (the “Company”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with Ocho Investments LLC (“Ocho”), the beneficial owner of 5,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Common S…

Filed Nov 16, 2026Accepted Nov 16, 2026, 8:00 AM ESTCIK 2119322Accession 0001437749-26-037017
Share

Company context

Digimarc (NASDAQ: DMRC) is building the trust layer for the modern world. As AI accelerates how we produce, share, and interact with the world, the risks of fraud, counterfeiting, and misinformation are growing exponentially. Our innovative, highly scalable, and ultra-secure solutions make it possible for consumers, businesses, and intelligent systems to instantly verify what’s real, protect what matters, and transact with confidence. Digimarc’s solutions for loss prevention, authentication, and digital are built to counter the speed and sophistication of today’s AI-enabled threats. Trusted by the world’s central banks to deter the counterfeiting of global currency, we exist to protect truth in every interaction, spanning both the physical and digital worlds. Learn more at Digimarc.com.

Current securities

Recent company filings

  1. SCHEDULE 13D/A - filed by Ocho Investments LLC regarding Digimarc CorpNov 17, 2026
  2. 4 filingNov 17, 2026
  3. 4 filingNov 17, 2026
  4. 4 filingNov 16, 2026
  5. 4 filingNov 16, 2026

Registered securities in this filing

DIGIMARC CORPORATION · 8-K · Filed 2026-11-16

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock

Symbol
DMRC
Exchange
NASDAQ
Classification
COMMON
Status
Current
Filing context

Context: d20268K

Dimensions: Not supplied

Accession 000143774926037017 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 1.01, 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 1.01Item 1.01 - Entry into Material Agreement
Item 1.01. Entry into a Material Definitive Agreement Cooperation Agreement with Ocho Investments LLC On November 15, 2026 (the “Effective Date”), Digimarc Corporation (the “Company”) entered into a Cooperation Agreement (the “Cooperation Agreement”) with Ocho Investments LLC (“Ocho”), the beneficial owner of 5,000,000 shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”), as of the Effective Date. The Cooperation Agreement will remain in effect until the earlier of (a) December 31, 2027, and (b) the date that is thirty (30) days prior to the first day of the window pursuant to the bylaws of the Company for the submission of shareholder notice of director nominations for the Company’s 2028 annual meeting of shareholders (the “Termination Date”), unless it is earlier terminated in accordance with its terms. Pursuant to the Cooperation Agreement, on the Effective Date, the Board of Directors of the Company (the “Board”) (i) increased the size of the Board from eight (8) to eleven (11) directors; (ii) appointed Andris Upitis, Kevin McConnell and Amy O’Keefe (collectively, the “New Directors”) to fill the three (3) newly created vacancies resulting from the increase in the size of the Board, in each case, effective upon the Effective Date, with an initial term expiring at the Company’s 2027 annual meeting of shareholders (the “2027 Annual Meeting”) and until the director’s successor has been duly elected and qualified or the director’s earlier death, resignation or removal; (iii) appointed Mr. Upitis to the Governance, Nominating and Sustainability Committee (the “Nominating Committee”) and the Compensation and Talent Management Committee (the “Compensation Committee”), Mr. McConnell to the Nominating Committee, and Ms. O’Keefe to the Audit Committee and the Compensation Committee. On November 15, 2026, the Board accepted the resignations of each of Katie Kool, Sheila Cheston, Sandeep Dadlani and LaShonda Anderson-Williams, with such resignations effective December 31, 2026 (except that the resignations of Ms. Kool, Ms. Cheston, and Ms. Anderson-Williams, solely with respect to their membership on the Compensation Committee, are effective on the Effective Date). Under the terms of the Cooperation Agreement, the size of the Board will be capped as follows: (i) from the Effective Date until the effectiveness of the resignations on December 31, 2026, the size of the Board may not exceed eleven (11) directors and (ii) following the effectiveness of the resignations on December 31, 2026 and until the Termination Date, the size of the Board may not exceed nine (9) directors, in each case without the prior written consent of Ocho. The Cooperation Agreement provides that the Company will nominate each of the New Directors as a candidate for election to the Board at the 2027 Annual Meeting and recommend, support and solicit proxies for the election of such directors in a manner no less rigorous and favorable than the manner in which the Company supports its other nominees for election at such meeting. The Company and Ocho also agreed that, in lieu of the Board renominating any New Director, or any person then serving on the Board who is neither a New Director nor a member of the Board as of the Effective Date (an “Additional Director”), for election to the Board by shareholders at the 2027 Annual Meeting, Ocho will have the right to designate a replacement person to be nominated by the Board for election at the 2027 Annual Meeting (a “Replacement Candidate”) to take the place of such New Director or Additional Director, provided that only one (1) Additional Director may be replaced by a Replacement Candidate, and subject to the Replacement Candidate being deemed reasonably acceptable by the Nominating Committee and the other conditions described in the Cooperation Agreement. In addition, if any New Director ceases to serve as a director prior to the Termination Date, Ocho will have the right to designate a substitute director, subject to the conditions described in the Cooperation Agreement. Pursuant to the Cooperation Agreement, Ocho agreed to vote all of the shares of the Common Stock that it beneficially owns and has the right to vote in accordance with the Board’s recommendations with respect to the election, removal or replacement of any director of the Company and on all other proposals that may be the subject of shareholder action at shareholder meetings held prior to the Termination Date, except (i) if Institutional Shareholder Services Inc. or Glass Lewis & Co., LLC recommend against the Board’s recommendation for a proposal, Ocho may follow such alternative recommendation, subject to certain exceptions, and (ii) Ocho may vote in its sole discretion in respect of (x) any Extraordinary Transaction (as defined in the Cooperation Agreement), (y) the ratification or approval of any shareholder rights plan, and (z) any amendment to the articles of incorporation or bylaws of the Company that would reasonably be expected to adversely affect the rights of shareholders of the Company. The Cooperation Agreement includes certain customary non-disparagement provisions, standstill restrictions, no-litigation covenants, confidentiality obligations, and expense reimbursement provisions. The Company’s Chief Executive Officer and President, Paul Carreiro, has agreed that, if approved by the Compensation Committee, his existing compensation arrangements (the “CEO Compensation Agreements”) will be modified such that (i) Mr. Carreiro would not be entitled to any benefits under the CEO Compensation Agreements arising from the occurrence of a “Change of Control Event,” “Change in Control,” “Change of Control,” “Company Transaction,” or any similar term used therein, in connection with the changes to the Board effected under the Cooperation Agreement; (ii) Mr. Carreiro’s long-term incentive plan units would partially accelerate upon his termination without Cause (as defined in the applicable CEO Compensation Agreements); and (iii) the stock price thresholds applicable to Mr. Carreiro’s performance vesting units would be reduced. The foregoing modifications are subject to the approval of the Compensation Committee, which may approve or reject the modifications in its sole discretion. If the Compensation Committee does not approve such modifications within certain time frames, then Mr. Carreiro, on or after January 1, 2027, may terminate his agreement to enter into such modifications. The foregoing summary of the Cooperation Agreement does not purport to be complete and is subject to, and qualified in its entirety by, the full text of the Cooperation Agreement, which is attached hereto as Exhibit 10.1 and incorporated herein by reference.
Item 5.02Item 5.02 - Departure/Election of Directors
Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The information set forth under Item 1.01 of this Current Report on Form 8-K is incorporated herein by reference. There is no arrangement or understanding between any of the New Directors and any other persons pursuant to which any of the New Directors was appointed as a director of the Company, other than with respect to the matters referred to in Item 1.01. Furthermore, there are no family relationships between any of the New Directors and any other director or executive officer of the Company and, other than with respect to the matters referred to in Item 1.01 and the agreements between the Company and Ocho (of which Mr. Upitis is a principal) that were previously reported on the Current Report on Form 8-K filed by the Company on September 30, 2026, the description of which is incorporated by reference herein, there are no transactions between any of the New Directors and the Company that would be required to be reported under Item 404(a) of Regulation S-K. As non-employee directors of the Company, the New Directors will be compensated according to the Company’s non-employee director compensation practices, which are described under the heading “Director Compensation” in the Company’s proxy statement for its 2026 annual meeting of shareholders, which was filed with the U.S. Securities and Exchange Commission on March 24, 2026. This compensation consists in part of an annual retainer for service on the Board in the amount of $50,000 and an additional annual retainer in the amount of $40,000 for the Chair of the Board and $15,000 for each of the Chairs of the Audit Committee, the Compensation Committee and the Nominating Committee, which retainers are paid quarterly in arrears. Each of the New Directors has elected to receive 100% of the director’s retainer in shares of common stock of the Company, instead of in cash, where the value of the issued shares will be equal to 100% of the director’s cash retainer payment and will be issued on the same date as such quarterly payments would otherwise be made in cash. Additionally, effective upon the appointment of the New Directors, each New Director was granted an initial award of shares of restricted common stock of the Company having an aggregate value of approximately $200,000. These shares vest over the three-year period commencing on the date of grant, with 1/3 of the shares vesting on each of the first three anniversaries of the date of grant. Each New Director was also automatically granted a prorated annual award of shares of restricted common stock of the Company having an aggregate value of approximately $45,418.33 that will vest on the first anniversary of the grant date, or immediately prior to the next annual meeting of shareholders that occurs prior to such first anniversary, but at least 50 weeks after the prior year’s annual meeting of shareholders. The Company will also enter into a standard form of indemnification agreement with the New Directors. On November 15, 2026, each of Katie Kool, Sheila Cheston, Sandeep Dadlani and LaShonda Anderson-Williams tendered their resignations from the Board, with such resignations to be effective as of December 31, 2026 (except that the resignations of Ms. Kool, Ms. Cheston, and Ms. Anderson-Williams, solely with respect to their membership on the Compensation Committee, are effective on the Effective Date). None of these directors’ decision to resign is as a result of any disagreement between such director and the Company on any matter relating to the Company’s operations, policies or practices.
Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On November 16, 2026, the Company issued a press release announcing the execution of the Cooperation Agreement, the appointment of each of the New Directors to the Board, and the resignation of each of Ms. Kool, Ms. Cheston, Mr. Dadlani and Ms. Anderson-Williams. The information furnished in Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.